#9650
Fasciola
hepatica IgG ELISA (Trematoda)
ELISA kit for the diagnosis of human fascioliasis
Lot 2306D (Expiry date: 14.10.2024)
Production date : 15.02.2023
Results of quality control 2 (after
6 months), date: 14.08.2023
No serum blank (average) : 0.125
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.002 |
-0.002 |
0.005 |
-0.002 |
0.000 |
0 |
Negative control serum
(N° 9650-06) |
0.103 |
0.114 |
0.175 |
0.113 |
0.126 |
4 |
Weak positive serum
(N° 9650-07) |
0.469 |
0.492 |
0.488 |
0.485 |
0.483 |
17 |
Positive control
serum
(N° 9650-08) |
2.708 |
2.980 |
2.701 |
2.967 |
2.839 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9650-08 |
> 1.200 |
2.839 |
Yes |
Absorbance of weak positive serum 9650-07, as % of positive serum |
> 8 % |
17 % |
Yes |
Absorbance of negative serum 9650-06, as % of positive serum |
< 8 % |
4 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.125 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|